NEW YORK (GenomeWeb) – Natural Molecular Testing, currently in Chapter 11 reorganization, has reached a settlement with the Centers for Medicare and Medicaid Services to pay back the agency $71.1 million in overpayments received by NMT. 

In court documents filed on Thursday in US Bankruptcy Court, Western District of Washington at Seattle, the trustee for NMT said the firm will cease all operations, end its plans to reorganize, and liquidate its assets. 

Under the terms of the settlement, NMT will begin repaying CMS after it has paid other creditors $1 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.